Research project

Precision Targeting of human iNKT Cells for Cancer Immunotherapy

Project overview

Exploiting iNKT cells for cancer treatment

Staff

Lead researchers

Dr Salah Mansour PhD

Associate Professor
Research interests
  • Unconventional T cells and lipid antigen recognition in human disease
  • CD1-restricted T cell immunity, including group 1 CD1, iNKT and γδ T cells
  • Molecular and structural mechanisms of CD1-mediated antigen presentation
Connect with Salah

Dr Ali Roghanian PhD, FHEA

Associate Professor
Research interests
  • Cancer immunotherapy
  • Monoclonal antibodies
  • Cellular therapies (e.g., CAR T and iNKT cells)
Connect with Ali

Dr Diana Garay Baquero

Research Fellow
Connect with Diana

Research outputs